[1]
Mija, L.A. and Elkrief, A. 2025. Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?. Canadian Oncology Today. 2, 1 (Apr. 2025), 13–17. DOI:https://doi.org/10.58931/cot.2025.2131.